// App-Quantinova.ai

1910 : Prognostic Impact of Measurable Residual Disease on Survival in Acute Myeloid Leukemia: A Meta-Analysis of 81 Studies

Researchers

Presenter

  • Nicholas J. Short

Principal Investigators

  • Shouhao Zhou

  • Chenqi Fu

  • Donald Berry

  • Roland P Walter

  • Sylvie D Freeman

  • Christopher S. Hourigan

  • Xuelin Huang

  • Graciela M. Nogueras Gonzlez

  • Hyunsoo Hwang

  • Xinyue Qi

  • Hagop M. Kantarjian

  • Farhad Ravandi

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Public Health Sciences, Penn State College of Medicine, Hershey, PA

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom

  • Laboratory of Myeloid Malignancies, Hematology Branch, NHLBI, Bethesda, MD

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved